Moneycontrol PRO
cadila healthcare
Jump to
888 Results Found
  • Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher Oct 06, 2021 05:39 PM IST

    Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher

    Net Sales are expected to decrease by 3.5 percent Y-o-Y (down 8.4 percent Q-o-Q) to Rs 3,685.8 crore, according to Prabhudas Lilladher.

  • Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine Sep 24, 2021 03:02 PM IST

    Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine

    The company has, "entered into a definitive agreement with Shilpa Medicare, via its wholly owned subsidiary, Shilpa Biologicals for production-supply of the ZyCoV-D vaccine drug substance from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka," Cadila Healthcare said in a regulatory filing.

  • Cadila Healthcare share price falls on sale of two brands Sep 21, 2021 09:35 AM IST

    Cadila Healthcare share price falls on sale of two brands

    Purchaser is a part of the portfolio companies of PE firm True North and said the transaction is not a related party transaction.

  • Cadila Healthcare unit inks pact to sell two brands to Integrace Sep 20, 2021 06:34 PM IST

    Cadila Healthcare unit inks pact to sell two brands to Integrace

    Zydus Healthcare Ltd, a wholly-owned subsidiary of the company, has inked the agreement with Integrace, a part of the portfolio companies of private equity firm True North.

  • Buy Cadila Healthcare target of Rs 695: Prabhudas Lilladher Aug 24, 2021 05:45 PM IST

    Buy Cadila Healthcare target of Rs 695: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 695 in its research report dated dated August 24, 2021.

  • Buy Cadila Healthcare; target of Rs 720: Sharekhan Aug 23, 2021 01:55 PM IST

    Buy Cadila Healthcare; target of Rs 720: Sharekhan

    Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated August 11, 2021.

  • Cadila: Vaccine opportunity unfolds Aug 23, 2021 10:38 AM IST

    Cadila: Vaccine opportunity unfolds

    On conservative basis, for COVID vaccine opportunity, Cadila can at least add 16 per cent of FY21 sales revenue, on a full-year basis

  • Cadila Healthcare share price rises 7% after DCGI approves ZyCoV-D COVID vaccine Aug 23, 2021 09:32 AM IST

    Cadila Healthcare share price rises 7% after DCGI approves ZyCoV-D COVID vaccine

    ZyCoV-D is the world’s first Plasmid DNA Vaccine for COVID-19

  • Buy Cadila Healthcare; target of Rs 670: Motilal Oswal Aug 19, 2021 02:14 PM IST

    Buy Cadila Healthcare; target of Rs 670: Motilal Oswal

    Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 11, 2021.

  • What should investors do with Cadila Healthcare after Q1 earnings: buy, sell or hold? Aug 12, 2021 09:34 AM IST

    What should investors do with Cadila Healthcare after Q1 earnings: buy, sell or hold?

    The pharma company reported a 29 percent year-on-year jump in net profit at Rs 587 crore for the quarter ended June 30 led by strong growth in domestic formulation business and COVID-19 drug sales

  • Cadila Health Consolidated June 2021 Net Sales at Rs 4,025.40 crore, up 10.59% Y-o-Y Aug 11, 2021 03:33 PM IST

    Cadila Health Consolidated June 2021 Net Sales at Rs 4,025.40 crore, up 10.59% Y-o-Y

  • Cadila Health Standalone June 2021 Net Sales at Rs 2,123.40 crore, up 18.24% Y-o-Y Aug 11, 2021 03:22 PM IST

    Cadila Health Standalone June 2021 Net Sales at Rs 2,123.40 crore, up 18.24% Y-o-Y

  • Cadila Healthcare arm completes sale of animal health business for Rs 2,921 crore Jul 15, 2021 11:13 AM IST

    Cadila Healthcare arm completes sale of animal health business for Rs 2,921 crore

    "The transaction of sale and disposal is completed /closed today i.e. July 14, 2021," Cadila Healthcare said in a regulatory filing.

  • Cadila Healthcare Q1 PAT seen up 63.9% YoY to Rs 744 cr: KRChoksey Jul 13, 2021 11:55 AM IST

    Cadila Healthcare Q1 PAT seen up 63.9% YoY to Rs 744 cr: KRChoksey

    Net Sales are expected to increase by 8.7 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs 3,956 crore, according to KRChoksey.

  • Hold Cadila Healthcare; target of Rs 640: ICICI Direct Jun 01, 2021 10:35 AM IST

    Hold Cadila Healthcare; target of Rs 640: ICICI Direct

    ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 640 in its research report dated May 28, 2021.

  • Buy Cadila Healthcare: target of Rs 720: Sharekhan May 31, 2021 01:39 PM IST

    Buy Cadila Healthcare: target of Rs 720: Sharekhan

    Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 27, 2021.

  • Buy Cadila Healthcare; target of Rs 740: Motilal Oswal May 31, 2021 12:35 PM IST

    Buy Cadila Healthcare; target of Rs 740: Motilal Oswal

    Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 740 in its research report dated May 28, 2021.

  • Ideas For Profit | Cadila: COVID opportunity, complex pharma pipeline offer strong risk reward May 28, 2021 07:12 PM IST

    Ideas For Profit | Cadila: COVID opportunity, complex pharma pipeline offer strong risk reward

    Cadila’s stock was primed by a series of potential roll outs to meet the COVID-19 challenge. Beyond COVID, the company is steadily building up its injectable and biosimilars portfolio - the areas to look at for the longer term.

  • Cadila Health Consolidated March 2021 Net Sales at Rs 3,846.70 crore, up 2.52% Y-o-Y May 28, 2021 02:25 PM IST

    Cadila Health Consolidated March 2021 Net Sales at Rs 3,846.70 crore, up 2.52% Y-o-Y

  • Buy Cadila Healthcare; target of Rs 701: Dolat Capital Market May 28, 2021 12:45 PM IST

    Buy Cadila Healthcare; target of Rs 701: Dolat Capital Market

    Dolat Capital Market is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 701 in its research report dated May 28, 2021.

  • Accumulate Cadila Healthcare; target of Rs 678: Arihant Capital May 28, 2021 12:43 PM IST

    Accumulate Cadila Healthcare; target of Rs 678: Arihant Capital

    Arihant Capital recommended Accumulate rating on Cadila Healthcare with a target price of Rs 678 in its research report dated May 28, 2021.

  • Accumulate Cadila Healthcare target of Rs 696: Prabhudas Lilladher May 28, 2021 12:41 PM IST

    Accumulate Cadila Healthcare target of Rs 696: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Cadila Healthcare with a target price of Rs 696 in its research report dated May 28, 2021.

  • Cadila: All in for COVID while keeping a tab on complex pharma May 28, 2021 11:10 AM IST

    Cadila: All in for COVID while keeping a tab on complex pharma

    Cadila's stock has been primed by a series of potential rollouts to meet the COVID challenge

  • Cadila Health Standalone March 2021 Net Sales at Rs 2,018.80 crore, up 11.4% Y-o-Y May 28, 2021 09:22 AM IST

    Cadila Health Standalone March 2021 Net Sales at Rs 2,018.80 crore, up 11.4% Y-o-Y

  • Top Canadian pension fund CPPIB to increase India public equity exposure May 21, 2021 09:44 PM IST

    Top Canadian pension fund CPPIB to increase India public equity exposure

    In the past CPPIB has been selective in its approach and has participated in equity capital market deals like the SBI Life Insurance IPO, the Power Grid InvIT IPO and the Embassy Office Parks QIP.

Sections
ISO 27001 - BSI Assurance Mark